Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.

Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.

Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.

View all videos

ASH 2020

American Society of Hematology (ASH) Annual Meeting and Exposition
05–08 December 2020

Muhammad Umair Mushtaq (@KUMedCenter) discusses outcomes of alloHSCT in TP53-mutated AML and MDS:

👉http://ow.ly/I7PX50J8F9s👈

@ASTCT @CIBMTR #Tandem22 #MDSsm #LeuSM #AMLsm #Leukemia #MyelodysplasticSyndromes #HemOnc #BMTsm

2 weeks to go until #ASCO22! 🎉

We’re counting down to one of the biggest oncology congresses of the year – stay tuned with VJHemOnc for the highlights in hematological cancers! 👩‍⚕️👨‍⚕️

@ASCO

Pieter Sonneveld (@ErasmusMC) shares some insights on how to approach myeloma patients with high-risk cytogenetics at #COMy22.

Watch now:

🎥: http://ow.ly/LKlF50J8EW3

@COMyCongress #MMsm #HemOnc #Myeloma

Day 3 highlights from #COMy22 - we had such a lovely time!

Our expert-led interviews are now live on:

👉http://ow.ly/NxEa50JayAm👈

@COMyCongress @Mohty_EBMT @SagarLonialMD #MMsm #Myeloma #HemOnc

We're pleased to bring you our latest podcast! Join leading experts as they discuss the impact of artificial intelligence and machine learning in the treatment of MDS:

🎧: http://ow.ly/1Akr50J8EBm

#MDSsm #MyelodysplasticSyndromes

Load More...

ASH 2020

American Society of Hematology (ASH) Annual Meeting and Exposition
05–08 December 2020

Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.

Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.

Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.

View all videos

Muhammad Umair Mushtaq (@KUMedCenter) discusses outcomes of alloHSCT in TP53-mutated AML and MDS:

👉http://ow.ly/I7PX50J8F9s👈

@ASTCT @CIBMTR #Tandem22 #MDSsm #LeuSM #AMLsm #Leukemia #MyelodysplasticSyndromes #HemOnc #BMTsm

2 weeks to go until #ASCO22! 🎉

We’re counting down to one of the biggest oncology congresses of the year – stay tuned with VJHemOnc for the highlights in hematological cancers! 👩‍⚕️👨‍⚕️

@ASCO

Pieter Sonneveld (@ErasmusMC) shares some insights on how to approach myeloma patients with high-risk cytogenetics at #COMy22.

Watch now:

🎥: http://ow.ly/LKlF50J8EW3

@COMyCongress #MMsm #HemOnc #Myeloma

Day 3 highlights from #COMy22 - we had such a lovely time!

Our expert-led interviews are now live on:

👉http://ow.ly/NxEa50JayAm👈

@COMyCongress @Mohty_EBMT @SagarLonialMD #MMsm #Myeloma #HemOnc

We're pleased to bring you our latest podcast! Join leading experts as they discuss the impact of artificial intelligence and machine learning in the treatment of MDS:

🎧: http://ow.ly/1Akr50J8EBm

#MDSsm #MyelodysplasticSyndromes

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter